Express Pharma

NOVEMBER 26, 2024

Spanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond, it offers a comprehensive platform for stakeholders to engage in transformative dialogues and foster strategic partnerships. With exports nearing $27.84 VP- Advanced Biotech Lab, IPCA Labs; among other relevant topics.

Packaging 105

Packaging Biosimilars Pharmaceutical Manufacturing Dosage 105

Pharma Packaging Solutions

SEPTEMBER 22, 2023

For example, what is the difference between biologics and biosimilars? There are a few common types of biologics, including extracted (taken directly from a living system), semi-synthesized (produced with recombinant DNA technology), vaccines, and gene therapies. What are Biosimilars? That’s where biosimilars come in.

Biosimilars 52

Biosimilars Packaging Vaccines 52

Pharma in Brief

DECEMBER 3, 2020

Any authorization for drugs, vaccines, and medical devices issued pursuant to the interim orders are also set to terminate when the respective interim order expires or is withdrawn. Drugs and Vaccines. Both interim orders are set to expire 1 year after they were issued, or sooner if withdrawn by the Minister.

Vaccines 98

Vaccines Labelling Biosimilars Packaging 98

Express Pharma

JUNE 28, 2024

With a focus on redefining the pharmaceutical industry in the post-COVID era, PharmaLytica 2024 offered a platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and packaging, lab analytical and cleanroom solutions, and pharmaceutical ingredients.

Packaging 105

Packaging Biosimilars Labelling Vaccines 105

Express Pharma

JUNE 5, 2023

It has often been the leader in areas, such as the manufacture of generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research and manufacturing, biosimilars, and biologics. Also, the packaging in which drugs and other medication are delivered to end-consumers is undergoing certain changes.

Packaging 104

Packaging Vaccines Biosimilars 104

Pharmaceutical Technology

NOVEMBER 22, 2022

Despite China producing a significant proportion of the world’s API supply (mostly small molecule), it manufactures relatively few biosimilar and innovator drugs and no cell and gene therapies for the western markets of Europe and the US despite investments and an increasing number of startups to improve innovative manufacture.

Biosimilars 64

Biosimilars Packaging Vaccines 64

pharmaphorum

JANUARY 27, 2023

The same goes for many commodities used in the production process for key medicines, from solvents through to packaging. The recent reversal of China’s “zero Covid” policy, at a time when the country still lacks optimal vaccine coverage, has also created another unknown, in terms of global supply and demand forecasting.

Packaging 105

Packaging Biosimilars Vaccines 105